Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07732192) titled 'Oral Tranexamic Acid Plus Triple Combination vs Triple Combination Alone in Melasma' on July 23.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Combined Military Hospital Abbottabad

Condition: Melasma Melasma (Facial Melasma)

Intervention: Combination Product: Oral tranexamic acid + triple combination cream (fluocinolone acetonide + hydroquinone + tretinoin)

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: July 15, 2026

Target Sample Size: 128

To ...